HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Characteristics of patients with stage III and IV ovarian endometriomas and trends in postoperative anti-Mullerian hormone changes.

AbstractIntroduction:
This study aimed to investigate the manifestations of postoperative Anti-Mullerian hormone (AMH) changes in patients with stage III and IV ovarian endometriomas.
Methods:
Trends in postoperative AMH were categorized and described, and the risk factors for postoperative AMH decline were screened using dichotomous logistic regression.
Results:
The overall trend of postoperative AMH decreased, with a more significant decrease in stage IV than stage III cases. Elevated preoperative CA-125 levels, a history of caesarean section, and abortion were independent risk factors for postoperative AMH decline.
Conclusions:
There is a general trend toward decreasing AMH levels after surgery, but each case may also show a different elevation.
AuthorsKefei Gao, Wenqin Lian, Rui Zhao, Jian Xiong
JournalArchives of medical science : AMS (Arch Med Sci) Vol. 19 Issue 3 Pg. 800-804 ( 2023) ISSN: 1734-1922 [Print] Poland
PMID37313209 (Publication Type: Journal Article)
CopyrightCopyright: © 2023 Termedia & Banach.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: